ANNA PARTIN: Open Payments
NPI 1972115228 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 28 payments from 17 companies in 2025. Trend: 2023 $534 · 2024 $323 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $115 |
| ABBVIE INC. | 3 | $79 |
| Alkermes, Inc. | 3 | $68 |
| Lundbeck LLC | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: REXULTI, VRAYLAR, ARISTADA, FANAPT, CAPLYTA, TRINTELLIX, ABILIFY ASIMTUFII, SPRAVATO.
Industry payments across FL — which companies pay providers there.
